HFM
LSTA icon

Hartford Financial Management’s Lisata Therapeutics LSTA Stock Holding History

Hartford Financial Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11
Closed -$6K – 175
2014
Q4 		$6K Hold
11
– – ﹤0.01% 214
2014
Q3 		$9K Hold
11
– – 0.01% 216
2014
Q2 		$11K Buy
+11
New +$10.7K 0.01% 206

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Hartford Financial Management's LSTA Position: Q1 2015 in Review

Hartford Financial Management sold out of Lisata Therapeutics (LSTA) in Q1 2015, closing a stake of 11 shares — an estimated $6K sold.

Hartford Financial Management first reported a position in LSTA in Q2 2014 and held it in 3 quarters. The position peaked at $11K in Q2 2014. 52 funds tracked by Wall St. Rank hold LSTA as of Q1 2015.

  • Hartford Financial Management reported no remaining Lisata Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Hartford Financial Management sold 11 Lisata Therapeutics shares in Q1 2015, an estimated $6K.
  • Hartford Financial Management first reported a position in Lisata Therapeutics in Q2 2014 and held it in 3 quarters.
  • Hartford Financial Management's Lisata Therapeutics position peaked at $11K in Q2 2014.
  • 52 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2015.

Based on Hartford Financial Management's 13F filing for Q1 2015, filed 13 Apr 2015.